Locations:
Search
The VeloSano global footprint continues to grow as a fundraising movement
One-time infusion of investigational CRISPR-Cas9 therapy found to safely reduce LDL cholesterol by 50% and triglycerides by about 55% in Phase 1 trial
All six patients in the small early phase trial are no longer symptomatic
Discovery reveals new disease pathway tied to how the heart uses certain fuels to generate energy; Cleveland Clinic to lead next stage of translational research through new cardiovascular genomics initiative
Innovation, treatments and breakthrough research told through the eyes of inspiring patients and doctors.
View our storiesServices include fulfilling requests for live, remote and pre-recorded interviews, as well as providing a range of assets such as infographics, photos and b-roll footage.
Resources for journalists
